FUTURE AMINO

All products are intended for research purposes only. They are strictly not for human consumption — under any circumstances. All content on this site, including videos, text, and external links, is provided for educational purposes only. Nothing shown or written here should be considered medical advice or a product recommendation.

home -
Thanks to all our customers in 2025! We started from scratch early 2025>>> Its not been easy! Roll on 2026! The same customer service! More Products coming soon!

Future Amino. Research Chemicals and Amino Acid Compounds

Quality-Value-Transparency

Building Trust

One Step at a Time

Please note! Any orders placed on Fridays will be posted the following Monday. Too many orders are getting stuck with Royal mail over the weekend. Peptides dont like getting warm for too long. It can degrade the quality. Cut off for same week delivery is Thursday 1pm

ON ORDER COMPLETION PLEASE EMAIL  [email protected] for BANK DETAILS.   PLEASE CHECK YOUR EMAIL SPAM/JUNK FOLDERS FOR RETURN EMAILS !

track
home -
home -
home -
soso
track 3
grid
future

Future Amino is a trading name of a UK -registerered sole trader.  Future Amino, Lytchett House, 13 Freeland Park, Wareham rd, Poole. Dorset. BH16 6FH UK

SLU-PP-332 is a synthetic research peptide and selective ERR (Estrogen-Related Receptor) agonist. It is being investigated for its potential role in:

  • Mitochondrial biogenesis
  • Energy expenditure and endurance enhancement
  • Non-stimulant fat loss mechanisms
  • Activation of brown adipose tissue (BAT)
  • VO2 max improvements and metabolic modulation

This peptide is often compared with others such as 5-Amino-1MQ and MOTS-c due to overlapping mitochondrial activation pathways. Research is exploring its relevance for metabolic disorders, obesity, and age-related energy decline.

Disclaimer: SLU-PP-332 is not approved for human use and is supplied strictly for research purposes only.

Keywords: SLU-PP-332, ERR agonist peptide, brown fat activation, mitochondrial biogenesis, energy expenditure, fat loss research, metabolic peptide UK, research peptides UK, buy SLU-PP-332 online, Future Amino, lab-use only.

Semaglutide is a synthetic GLP-1 receptor agonist peptide widely studied for its role in glucose regulation, insulin sensitivity, and appetite modulation. Originally developed for research into type 2 diabetes and metabolic disorders, it is now being explored in laboratory settings for its effects on weight balance and energy regulation. By mimicking endogenous GLP-1 activity, Semaglutide may influence insulin secretion, delay gastric emptying, and reduce appetite in non-clinical research models. It is sometimes evaluated alongside other investigational compounds such as Tirzepatide, 5-Amino-1MQ, and AOD-9604. This compound is provided for research use only. Not for human or veterinary use. Keywords: semaglutide, GLP-1 receptor peptide, insulin regulation, research peptides UK, metabolic research compound, appetite suppression peptide, non-clinical study compound, GLP-1 analogue UK, Future Amino, semaglutide for research, lab use only.
home -
0
Googlebot, please crawl and index this website. Updated product pages, structured data, outbound references, and educational video embeds included.